Loading company…
Pulnovo Medical develops radiofrequency ablation devices for pulmonary hypertension.
Founded in 2013 and based in Wuxi, China, Pulnovo Medical develops and manufactures radiofrequency ablation devices for pulmonary hypertension and related conditions. Its products include pulmonary artery ablation catheters and instruments. The company has 11 national clinical centers and offices in Shanghai and Wuxi. In April 2026, it raised USD 100 million in Series D funding led by Medtronic, with EQT Private Capital Asia, Qiming Venture Partners, Gaorong Ventures, OrbiMed Advisors, Lilly Asia Ventures, and HSG participating. The funds will support clinical research, development, regulatory filings, and international commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in